Anhui Huangshan Capsule Co., Ltd. (SHE:002817)
6.19
-0.08 (-1.28%)
Nov 13, 2026, 3:04 PM CST
Anhui Huangshan Capsule Revenue
Anhui Huangshan Capsule had revenue of 94.21M CNY in the quarter ending September 30, 2026, a decrease of -5.98%. This brings the company's total for the last twelve months to 401.11M, down -14.85% year-over-year. In the year 2025, Anhui Huangshan Capsule had annual revenue of 460.42M, down -2.76%. That makes Anhui Huangshan Capsule the 26,593rd largest company in the world by revenue and 4,652nd in China.
Revenue (ttm)
401.11M
Revenue Growth
-14.85%
P/S Ratio
4.62
Revenue / Employee
627.71K
Employees
639
Market Cap
1.85B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Anhui Huangshan Capsule breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 460.42M | -13.06M | -2.76% |
| Dec 31, 2024 | 473.48M | 10.71M | 2.31% |
| Jan 1, 2024 | 462.77M | 34.45M | 8.04% |
| Jan 1, 2023 | 428.32M | 48.43M | 12.75% |
| Dec 31, 2021 | 379.89M | 60.46M | 18.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enwei Pharmaceutical | 829.24M |
| Zhejiang Shengda Bio-Pharm | 816.35M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 797.57M |
| Hainan Huluwa Pharmaceutical Group | 612.37M |
| Chengdu huasun technology group Inc. , LTD. | 421.93M |
| Zhejiang Shapuaisi Pharmaceutical | 408.66M |
| Honz Pharmaceutical | 335.59M |
| Guhan Pharmaceutical Group | 332.96M |